Regenerative medicine firm says new capital give
Author: Michael
FDA clears ENV-308 for Phase 1 as Enveda doses f
Funding accelerates clinical rollout of glycan b
From insulin to GLP-1s, peptide therapies harnes
Urolithin A may support healthier immune aging.
PeptiDream and Alnylam Pharmaceuticals announced
Alnylam Pharmaceuticals said it will invest about
Beacon Biosignals said it has formed a collabor
The fastest-growing supplements of 2025 reveal w
Fountain Life, a health and longevity brand focus